Antithrombotic drugs for the secondary prevention of ischemic stroke

Annali Italiani di Medicina Interna

Volumn 15, Issue 4, 2000, Pages 282-290

  Nenci, G G ^a   Goracci, S ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; INDOBUFEN; TICLOPIDINE; WARFARIN;

ANTICOAGULANT THERAPY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; NEUTROPENIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; TREATMENT INDICATION;

ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; ASPIRIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DIPYRIDAMOLE; FIBRINOLYTIC AGENTS; HUMANS; META-ANALYSIS; PHENYLBUTYRATES; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0034491375     PISSN: 03939340     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Mortality by cause for eight regions of the world: Global Burden of Disease Study
2. Stroke prevention and educational awareness diffusion
3. Collaborative overview of randomised trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
4. Swedish Aspirin Low-Dose Trial (SALT), 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
5. A comparison of two doses of aspirin (30 mg vs 238 mg a day) in patients after a transient ischemic attack or minor ischemic stroke
6. The United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial: Final results
7. Low dose aspirin and stroke. "It ain't necessarily so"
8. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: Case-control study
9. Influence of aspirin in the management of asymptomatic carotid artery stenosis. VA Cooperative Study Group on asymptomatic carotid stenosis
10. Results of a randomized controlled trial of carotid endoarterectomy for asymptomatic stenosis
11. Asymptomatic cervical bruit and abnormal ocular pneumoplethysmography: A prospective study comparing two approaches to management
12. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group
13. Endoarterectomy for asymptomatic carotid artery stenosis
14. Stenoses carotidiennes asymptomatiques
15. Endoarterectomy for asymptomatic carotid stenosis: A meta-analysis
16. Consensus statement on asymptomatic carotid stenosis
17. Controlled trial of aspirin in cerebral ischemia. Part II: Surgical group
18. Danish very low dose aspirin after carotid endarterectomy trial
19. Antiplatelet therapy following carotid bifurcation endarterectomy. Evaluation of a controlled clinical trial. Prognostic significance of histologic plaque examination on behalf of survival
20. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomised trial
21. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomised controlled trial
22. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke
23. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients
24. A randomised trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS). Ticlopidine Indobufen Stroke Study
25. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
26. European Stroke Prevention Study-2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
27. Second European Stroke Prevention Study: Antiplatelet therapy is effective regardless of age
28. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia
29. Persantinaspirin trial in cerebral ischemia. Part II: Endpoint results
30. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
31. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators
32. A prostacyclinsparing effect of indobufen vs aspirin
33. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
34. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
35. Anticoagulants versus aspirin and the combination of aspirin and dipyridamole versus aspirin only in patients with transient ischaemic attacks or nondisabling ischaemic stroke: ESPRIT (European and Australian Stroke Prevention in Reversible Ischemia Trial)
36. Randomised double-blind of fixed low-dose warfarin with aspirin after myocardial infarction
37. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
38. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulant or Aspirin Study): A randomised trial
39. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
40. Cholesterol reduction and the risk for stroke in men
41. Reductase inhibitor monotherapy and stroke prevention
42. Effect of HMG-CoA reductase inhibitors on stroke
43. Reduction of stroke incidence after myocardial infarction with pravastatin. The Cholesterol and Recurrent Events (CARE) study
44. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Sirnvastatin Survival Study (4S)
45. Prevention of vascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
46. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
47. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
48. Statins and cerebrovascular disease: Plaque attack to prevent brain attack